By Influencing Inflammation, GLP-1s May Lower Alzheimer's and Dementia Risk

(MedPage Today) -- SAN DIEGO--New data explored the potential beneficial impact that glucagon-like peptide-1 (GLP-1) receptor agonists may have on neurodegenerative diseases.
In a plenary session at the annual American Academy of Neurology...